Randomized trial of non-invasive ventilation combined with exercise training in patients with chronic hypercapnic failure due to chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 108, Issue 12, 2014, Pages 1741-1751

  Márquez Martín, Eduardo ^a,b   Ruiz, Francisco Ortega ^a,b,c   Ramos, Pilar Cejudo ^a,b   López Campos, Jose Luis ^a,b,c   Azcona, Borja Valencia ^a   Cortés, Emilia Barrot ^a,b,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Instituto de Biomedicina de Sevilla   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

COPD; Exercise capacity; Exercise training; Non invasive; Respiratory muscle training; Ventilation

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CARBON DIOXIDE; OXYGEN;

ADULT; AGED; AIRWAY PRESSURE; ARTICLE; BLOOD GAS; BLOOD GAS PARAMETERS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; EXERCISE; FEMALE; GAS EXCHANGE; HUMAN; HYPERCAPNIA; INFLAMMATION; INTERMETHOD COMPARISON; LUNG FUNCTION; MALE; MUSCLE STRENGTH; NONINVASIVE VENTILATION; OXYGEN CONSUMPTION; OXYGEN THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; BLOOD; COMPLICATION; KINESIOTHERAPY; LUNG GAS EXCHANGE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRESSURE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY;

AGED; BIOMARKERS; CARBON DIOXIDE; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; MUSCLE STRENGTH; NONINVASIVE VENTILATION; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE; QUALITY OF LIFE; RESPIRATORY INSUFFICIENCY;

EID: 84927604825     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.10.005     Document Type: Article

References (48)

1. Troosters T, Casaburi R, Gosselink R, Decramer Ml. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 19-38.
2. Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013; 6: CD002878. http://dx.doi.org/10.1002/14651858.CD002878.pub2.
3. Budweiser S, Hitzl AP, Jorres RA, Heinemann F, Arzt M, Schroll S, Pfeifer M. Impact of noninvasive home ventilation on long-term survival in chronic hypercapnic COPD: a prospective observational study. Int J Clin Pract 2007; 61: 1516-22.
4. Celli B, Lee H, Criner G, Bermudez M, Rassulo J, Gilmartin M, Miller G, Make B. Controlled trial of external negative pressure ventilation in patients with severe chronic airflow obstruction. Am Rev Respir Dis 1989; 140: 1251-6.
5. Garrod R, Mikelsons C, Paul EA, Wedzicha JA. Randomized controlled trial of domiciliary non-invasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1335-41.
6. Duiverman ML, Wempe JB, Bladder G, Jansen DF, Kerstjens HA, Zijlstra JG, Wijkstra PJ. Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax 2008; 93: 1052-7.
7. Köhnlein T, Schönheit-Kenn U, Winterkamp S, Welte T, Kenn K. Noninvasive ventilation in pulmonary rehabilitation of COPD patients. Resp Med 2009; 103: 1329-36.
8. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for chronic obstructive pulmonary disease (GOLD). Workshop summary. Am J Respir Crit Care Med 2007; 176: 532-55.
9. McEvoy RD, Pierce RJ, Hillman D, Estreman A, Ellis EE, Catcheside PG, O'Donoghue FJ, Barnes DJ, Grunstein RR. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomized controlled trial. Thorax 2009; 64: 561-6.
10. Ortega Ruiz F, Díaz Lobato S, Galdiz Iturri JB, García Rio F, Güell Rous R, Morante Velez F, Puente Maestu L, Tàrrega Camarasa J. Oxigenoterapia continua domiciliaria. Arch Bronconeumol 2014; 50: 185-200.
11. Ortega F, Toral J, Cejudo P, Villagomez R, Sánchez H, Castillo J, Montemayor T. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 669-74.
12. Maltais F, Leblanc P, Jobin J, Bruneau J, Carrier L, Breton MJ, Falardeau G, Belleau R. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 555-61.
13. Lillegard WA, Terrio JD. Appropriate strength training. Med Clin North Am 1994; 78: 457-77.
14. American Thoracic Society; American College of Chest Physicians. ATS/ACCP. Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-77.
15. Ward SA, Palange P. Clinical exercise testing. European respiratory monograph. Plymouth, UK: E.R.S. Latimer Trend and Co. Ltd; 2007.
16. Ortega F, Montemayor T, Sanchez A, Cabello F, Castillo J. Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 747-51.
17. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12.
18. Recomendaciones de la Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR). Normativa para la espirometria forzada. Barcelona: Ed. Doyma; 1985.
19. Goldman HI, Becklake MR. Respiratory function test. Normal values at median attitudes and the prediction on normal results. Am Rev Tub 1959; 79: 457-67.
20. Altose MD Assessment and management of breathlessness. Chest 1985; 88:S77-83.
21. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-8.
22. Sweer L, Zwillich CW. Dyspnea in the patient with chronic obstructive pulmonary: etiology and management. Clin Chest Med 1990; 11: 417-45.
23. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 47: 733-78.
24. Guell R, Casan P, Sangenis M, Santís J, Morante F, Borras JM, Guyatt G. The Spanish translation and evaluation of a quality-of-life questionnaire in patients with chronic obstructive pulmonary disease. Arch Bronconeumol 1995; 31: 202-10.
25. Covey M, Collins EG, Reynertson SI, Dilling DF. Resistance training as a preconditioning strategy for enhancing aerobic exercise training outcomes in COPD. Respir Med 2014; 108: 1141-52.
26. Borghi-Silva A, Di Thommazo L, Pantoni CB, Mendes RG, Salvini Tde F, Costa D. Non-invasive ventilation improves peripheral oxygen saturation and reduces fatigability of quadriceps in patients with COPD. Respirology 2009; 14: 537-44.
27. Renston JP, DiMarco AF, Supininski GS. Respiratory muscle rest using nasal BIPAP ventilation in patients with stable severe COPD. Chest 1994; 105: 1053-60.
28. Ambrosino N, Cobelli F, Torbicki A, Opasich C, Pozzoli M, Fracchia C, Rampulla C. Hemodynamic effects of negative-pressure ventilation in patients with COPD. Chest 1990; 97: 850-6.
29. Funk G, Breyer M, Burghuber O, Kink E, Kirchheiner K, Kohansal R, Schmidt I, Hartl S. Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. Resp Med 2011; 105: 427-34.
30. Duiverman ML, Wempe JB, Bladder G, Vonk JM, Zijlstra JG, Kerstjens HA, Wijkstra PJ. Two-year home based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respir Res 2011; 12: 112.
31. Clini E, Sturani C, Rossi A, Viaggi S, Corrado A, Donner CF, Ambrosino N, Rehabilitation and Chronic Care Study Group, Italian Association of Hospital Pulmonologists (AIPO). The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-38.
32. Tsolaki V, Pastaka C, Karetsi, Zygoulis P, Koutsokera A, Gourgoulianis KI, Kostikas K. One-year non-invasive ventilation in chronic hypercapnic COPD: effect on quality of live. Respir Med 2008; 102: 904-11.
33. Köhnlein T, Windisch W, Köhler D, Drabik A, Geiseler J, Hartl S, Karg O, Laier-Groeneveld G, Nava S, Schönhofer B, Schucher B, Wegscheider K, Criée CP, Welte T. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014; 2: 698-705.
34. Güell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, Sanchis J. Long term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000; 117: 976-83.
35. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005; 26: 630-6.
36. Casanova C, Celli B, Tost L, Soriano E, Abreu J, Velasco V, Santolaria F. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 2000; 118: 1582-90.
37. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for patients with pulmonary obstructive pulmonary disease. J Gen Intern Med 2003; 18: 213-21.
38. Wijkstra PJ, Van der Mark TW, Kraan J, van Altena R, Koëter GH, Postma DS. Long-term effects of home rehabilitation on physical performance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1234-41.
39. Jehn M, Schindler C, Meyer A, Tamm M, Roehler F, Witt C, Schmidt-Tcucksäss A, Stolz A. Associations of daily walking activity with biomarkers related to cardiac distress in patients with chronic obstructive pulmonary disease. Respiration 2013; 85: 195-202.
40. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer R, ECLIPSE investigators. Evaluation of COPD longitudinally to identify predictive subrrogate endpoints (ECLIPSE). Eur Respir J 2008; 3: 869-73.
41. Gan WQ, Man SFP, Senthilselvan Sin DD Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review. Thorax 2004; 59: 574-80.
42. Paone G, Conti V, Biondi-Zoccai G, De Falco E, Chimenti I, Peruzzi M, Mollica C, Monaco G, Giannunzio G, Brunetti G, Schmid G, Ranieri VM, Frati G. Long-term home noninvasive mechanical ventilation increases systemic inflammatory response in chronic obstructive pulmonary disease: a prospective observational study. Mediat Inflamm 2014. http://dx.doi.org/10.1155/2014/503145 [Epub 2014 May 25].
43. Rabinovich RA, Figueras M, Ardite E, Carbó N, Troosters T, Filella X, Barberà JA, Fernandez-Checa JC, Argilés JM, Roca J. Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 2003; 21: 789-94.
44. Bolton CE, Broekhuizen R, Ionescu AA, Nixon LS, Wouters EF, Shale DJ, Schols AM. Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD. Thorax 2007; 62: 109-14.
45. Vogiatzis I, Stratakos G, Simoes DC, Terzis G, Georgiadou O, Roussos C, Zakynthinos S. Effects of rehabilitative exercise on peripheral muscle TNFalpha, L-6, IGF-I and MyoD expression in patients with COPD. Thorax 2007; 62: 950-6.
46. Hoegh SV, Sorensen GL, Tornoe I, Lottenburger T, Ytting H, Nielsen HJ, Junker P, Holmskov U. Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology 2010; 215: 314-30.
47. Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009; 34: 95-102.
48. Sin DD, Leung R, Gan WQ, Man SP. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007; 7: 13.